170 related articles for article (PubMed ID: 23647650)
21. Quinoline alkaloids from Lunasia amara inhibit Mycobacterium tuberculosis H37Rv in vitro.
Aguinaldo AM; Dalangin-Mallari VM; Macabeo AP; Byrne LT; Abe F; Yamauchi T; Franzblau SG
Int J Antimicrob Agents; 2007 Jun; 29(6):744-6. PubMed ID: 17399957
[No Abstract] [Full Text] [Related]
22. FtsZ: a novel target for tuberculosis drug discovery.
Huang Q; Tonge PJ; Slayden RA; Kirikae T; Ojima I
Curr Top Med Chem; 2007; 7(5):527-43. PubMed ID: 17346197
[TBL] [Abstract][Full Text] [Related]
23. Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines.
Asquith CRM; Fleck N; Torrice CD; Crona DJ; Grundner C; Zuercher WJ
Bioorg Med Chem Lett; 2019 Sep; 29(18):2695-2699. PubMed ID: 31378571
[TBL] [Abstract][Full Text] [Related]
24. Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model.
Knudson SE; Awasthi D; Kumar K; Carreau A; Goullieux L; Lagrange S; Vermet H; Ojima I; Slayden RA
J Antimicrob Chemother; 2015 Nov; 70(11):3070-3. PubMed ID: 26245639
[TBL] [Abstract][Full Text] [Related]
25. Bioevaluation of quinoline-4-carbonyl derivatives of piperazinyl-benzothiazinones as promising antimycobacterial agents.
Sahoo SK; Gajula SNR; Ahmad MN; Kaul G; Nanduri S; Sonti R; Dasgupta A; Chopra S; Yaddanapudi VM
Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200168. PubMed ID: 35876343
[TBL] [Abstract][Full Text] [Related]
26. 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ.
White EL; Suling WJ; Ross LJ; Seitz LE; Reynolds RC
J Antimicrob Chemother; 2002 Jul; 50(1):111-4. PubMed ID: 12096015
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents.
Borsoi AF; Paz JD; Abbadi BL; Macchi FS; Sperotto N; Pissinate K; Rambo RS; Ramos AS; Machado D; Viveiros M; Bizarro CV; Basso LA; Machado P
Eur J Med Chem; 2020 Apr; 192():112179. PubMed ID: 32113048
[TBL] [Abstract][Full Text] [Related]
28. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
Shruthi TG; Eswaran S; Shivarudraiah P; Narayanan S; Subramanian S
Bioorg Med Chem Lett; 2019 Jan; 29(1):97-102. PubMed ID: 30448235
[TBL] [Abstract][Full Text] [Related]
30. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
31. Novel Furan Coupled Quinoline Diamide Hybrid Scaffolds as Potent Antitubercular Agents: Design, Synthesis and Molecular Modelling.
Rajpurohit A; Satyanarayan ND; Pathak L; Ayyanar S; Rishinaradamangalam CR; Shoorapani P
Med Chem; 2020; 16(4):507-516. PubMed ID: 31483232
[TBL] [Abstract][Full Text] [Related]
32. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
[TBL] [Abstract][Full Text] [Related]
33. Variedly connected 1,8-naphthalimide-7-chloroquinoline conjugates: Synthesis, anti-mycobacterial and cytotoxic evaluation.
Shalini ; Johansen MD; Kremer L; Kumar V
Bioorg Chem; 2019 Nov; 92():103241. PubMed ID: 31518758
[TBL] [Abstract][Full Text] [Related]
34. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
[TBL] [Abstract][Full Text] [Related]
35. The structure, function, and regulation of Mycobacterium FtsZ.
Hong W; Deng W; Xie J
Cell Biochem Biophys; 2013 Mar; 65(2):97-105. PubMed ID: 22932926
[TBL] [Abstract][Full Text] [Related]
36. ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines.
Saxena AK; Alam M
Curr Top Med Chem; 2020; 20(29):2723-2734. PubMed ID: 32885753
[TBL] [Abstract][Full Text] [Related]
37. Conformationally-constrained indeno[2,1-c]quinolines--a new class of anti-mycobacterial agents.
Upadhayaya RS; Lahore SV; Sayyed AY; Dixit SS; Shinde PD; Chattopadhyaya J
Org Biomol Chem; 2010 May; 8(9):2180-97. PubMed ID: 20401395
[TBL] [Abstract][Full Text] [Related]
38. Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides.
Pitta E; Rogacki MK; Balabon O; Huss S; Cunningham F; Lopez-Roman EM; Joossens J; Augustyns K; Ballell L; Bates RH; Van der Veken P
J Med Chem; 2016 Jul; 59(14):6709-28. PubMed ID: 27348630
[TBL] [Abstract][Full Text] [Related]
39. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation.
Chen R; Zhang H; Ma T; Xue H; Miao Z; Chen L; Shi X
Bioorg Med Chem Lett; 2019 Sep; 29(18):2635-2637. PubMed ID: 31358466
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents.
Muscia GC; Buldain GY; Asís SE
Eur J Med Chem; 2014 Feb; 73():243-9. PubMed ID: 24412719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
